Plain-English translation of NCT05887102 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Neoplasms research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This pilot study is testing a pharmacy-based program called PACHA that aims to help breast cancer survivors take their adjuvant endocrine therapy (hormone therapy) as prescribed. Half of participating pharmacies will offer the new PACHA program alongside their usual services, while the other half will provide standard care. The program trains pharmacists to have supportive conversations with patients about their medication, help them manage side effects, and stay committed to their treatment plan.
Many breast cancer survivors struggle to take their hormone therapy consistently over the years it's prescribed, which can affect how well it works. This trial is testing whether specialized pharmacy support can help patients stick with this important medication and feel more confident managing their treatment.
If you join, you'll be assigned to either the standard pharmacy care group or the PACHA program group. If you're in the PACHA group, your pharmacist will have structured check-in conversations with you (by phone or in person) in the first month and again around 4 months, focusing on how you're managing side effects and staying on track with your medication. You'll also have access to videos and written guides about managing common side effects. The study involves surveys and interviews to understand how helpful the program is.
AI-generated summary from trial data · Aug 14, 2026 · Not medical advice
Canada